Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2

Vasohihibin‐2 (VASH2) is a homolog of vasohibin‐1 (VASH1) and is overexpressed in various cancers. Vasohihibin‐2 acts on both cancer cells and cancer microenvironmental cells. Previous analyses have shown that VASH2 promotes cancer progression and abrogation of VASH2 results in significant anticance...

Descripción completa

Detalles Bibliográficos
Autores principales: Horie, Sachiko, Suzuki, Yasuhiro, Yamamoto, Tsuyoshi, Obika, Satoshi, Mohri, Kohta, Kiyota, Chizuru, Ren, Qin, Warashina, Shota, Wada, Yasuhiro, Watanabe, Yasuyoshi, Mukai, Hidefumi, Sato, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475766/
https://www.ncbi.nlm.nih.gov/pubmed/37430466
http://dx.doi.org/10.1111/cas.15897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475766/
https://www.ncbi.nlm.nih.gov/pubmed/37430466
http://dx.doi.org/10.1111/cas.15897

Ejemplares similares